Additional Information

Description

BOTOX® Cosmetic (OnabotulinumtoxinA) 50 Units (1 vial) is a specialized cosmetic formulation revered for its ability to reduce facial wrinkles. Each vial contains a powdered form of the active ingredient, Botulinum Toxin Type A (onabotulinumtoxinA). Prior to administration, it must be reconstituted solely with 0.9% sterile, non-preserved saline solution.

Once opened and reconstituted, the solution should be stored in a refrigerator at temperatures between 2 to 8 degrees Celsius. It is imperative to utilize the reconstituted solution within 24 hours to maintain its effectiveness and safety profile.

To administer BOTOX® Cosmetic, a 30 to 33-gauge needle is recommended for injection. This ensures precision and minimizes discomfort for patients during the procedure.

For storage of unopened vials, refrigeration within the same temperature range is recommended. The 50-unit vial can be stored for up to 24 months, ensuring the stability and potency of the product until use.

Additional Information

Description

BOTOX cosmetic (OnabotulinumtoxinA) is a sterile injection that comes as a vacuum dried powder supplied in a single-dose vial for reconstitution. Each vial contains 100 Units of Clostridium botulinum type A neurotoxin complex, 0.9 mg of sodium chloride and 0.5 mg of Albumin Human in a vacuum-dried form without a preservative. The purified botulinum toxin of type A present in the dried powder is produced via fermentation of clostridium botulinum type A.

The injection is administered through intradermal, intramuscular and intradetrusor routes only. BOTOX Cosmetic (OnabotulinumtoxinA) is indicated in adults for temporarily improving the appearance of moderate to severe forehead lines linked to frontalis muscle activity. It is also used to improve lateral canthal lines in association with orbicularis oculi activity. Moreover, the BOTOX cosmetic is also indicated to improve glabellar lines associated with procerus muscle activity or corrugator. The cumulative dose must not exceed 400 units in an interval of 3 months. The injection is contraindicated in patients with a history of known hypersensitivity reaction towards botulinum toxin type A.